• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脱氢表雄酮经阴道给药治疗绝经后外阴阴道萎缩

Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy.

作者信息

Archer David F

机构信息

Department of Obstetrics and Gynecology, Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA.

出版信息

J Steroid Biochem Mol Biol. 2015 Jan;145:139-43. doi: 10.1016/j.jsbmb.2014.09.003. Epub 2014 Sep 6.

DOI:10.1016/j.jsbmb.2014.09.003
PMID:25201455
Abstract

The effects of intravaginal administration of dehydroepiandrosterone (DHEA) for the management of symptomatic vulvovaginal atrophy are reviewed. A literature search related to vulvovaginal atrophy, vaginal atrophy, atrophic vaginitis, estrogen, dehydroepiandrosterone, vulvar itching, burning, dryness, dyspareunia, and libido was performed. Relevant articles addressing the incidence, management, and outcome of DHEA therapy were identified and used for this Expert Opinion. DHEA compared to a placebo is an effective treatment improving symptoms of vaginal atrophy: dyspareunia, burning, itching, and dryness. Objective parameters of vaginal atrophy, specifically pH, vaginal maturation index (VMI), and investigator-evaluated changes in the vagina: moisture, epithelia integrity and color were improved compared to baseline and placebo. There were significant improvements in libido and dyspareunia with the intravaginal use of DHEA that contribute to improved quality of life for postmenopausal women. Dehydroepiandrosterone administered intravaginally on a daily basis is an effective treatment for symptoms, and signs of vulvovaginal atrophy along with libido in postmenopausal women. This article is part of a Special Issue entitled 'Essential role of DHEA'.

摘要

本文综述了经阴道给予脱氢表雄酮(DHEA)治疗有症状的外阴阴道萎缩的效果。我们进行了一项文献检索,内容涉及外阴阴道萎缩、阴道萎缩、萎缩性阴道炎、雌激素、脱氢表雄酮、外阴瘙痒、灼痛、干燥、性交困难和性欲。确定了有关DHEA治疗的发病率、管理和结果的相关文章,并用于本专家意见。与安慰剂相比,DHEA是一种有效的治疗方法,可改善阴道萎缩的症状:性交困难、灼痛、瘙痒和干燥。与基线和安慰剂相比,阴道萎缩的客观参数,特别是pH值、阴道成熟指数(VMI)以及研究者评估的阴道变化:湿度、上皮完整性和颜色均得到改善。经阴道使用DHEA可显著改善性欲和性交困难,有助于提高绝经后妇女的生活质量。每日经阴道给予脱氢表雄酮是治疗绝经后妇女外阴阴道萎缩症状、体征以及性欲的有效方法。本文是名为“DHEA的重要作用”的特刊的一部分。

相似文献

1
Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy.脱氢表雄酮经阴道给药治疗绝经后外阴阴道萎缩
J Steroid Biochem Mol Biol. 2015 Jan;145:139-43. doi: 10.1016/j.jsbmb.2014.09.003. Epub 2014 Sep 6.
2
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.阴道用脱氢表雄酮(DHEA)治疗中重度性交痛和阴道干燥、外阴阴道萎缩症状以及绝经后泌尿生殖系统综合征的疗效。
Menopause. 2018 Nov;25(11):1339-1353. doi: 10.1097/GME.0000000000001238.
3
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.阴道内使用脱氢表雄酮(DHEA)对中度至重度性交困难和阴道干燥、外阴阴道萎缩症状以及绝经后泌尿生殖综合征的疗效。
Menopause. 2016 Mar;23(3):243-56. doi: 10.1097/GME.0000000000000571.
4
Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy.每周两次阴道内使用脱氢表雄酮治疗外阴阴道萎缩的疗效降低。
Climacteric. 2015;18(4):590-607. doi: 10.3109/13697137.2014.992012. Epub 2015 Mar 3.
5
Vaginal DHEA to treat menopause related atrophy: a review of the evidence.阴道用脱氢表雄酮治疗绝经相关萎缩:证据回顾。
Maturitas. 2011 Sep;70(1):22-5. doi: 10.1016/j.maturitas.2011.06.005. Epub 2011 Jul 5.
6
Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial.奥昔布宁,一种非雌激素选择性雌激素受体调节剂,用于治疗绝经后外阴和阴道萎缩相关的阴道干燥:一项随机、安慰剂对照、III 期试验。
Maturitas. 2014 Jun;78(2):91-8. doi: 10.1016/j.maturitas.2014.02.015. Epub 2014 Mar 12.
7
Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.大豆(Glycine max (L.) Merr.)异黄酮阴道凝胶对绝经后女性上皮形态及雌激素受体表达的影响:一项为期12周的随机双盲安慰剂对照试验
Maturitas. 2014 Jul;78(3):205-11. doi: 10.1016/j.maturitas.2014.04.007. Epub 2014 May 6.
8
Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy.阴道内使用普拉睾酮对绝经后外阴阴道萎缩女性性功能障碍的影响。
J Sex Med. 2015 Dec;12(12):2401-12. doi: 10.1111/jsm.13045. Epub 2015 Nov 23.
9
Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator.使用阴道内给药器给予普拉睾酮阴道软胶囊的可接受性评估。
Gynecol Endocrinol. 2016;32(3):240-5. doi: 10.3109/09513590.2015.1110140. Epub 2016 Jan 6.
10
Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study.普拉睾酮对外阴阴道萎缩的主要症状具有相似的有益作用:52周开放标签研究。
Maturitas. 2015 May;81(1):46-56. doi: 10.1016/j.maturitas.2015.02.005. Epub 2015 Feb 16.

引用本文的文献

1
Testosterone positively regulates vagina NO-induced relaxation: an experimental study in rats.睾酮对阴道一氧化氮诱导的舒张起正向调节作用:一项大鼠实验研究。
J Endocrinol Invest. 2022 Jun;45(6):1161-1172. doi: 10.1007/s40618-022-01743-4. Epub 2022 Jan 24.
2
Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause.与其他治疗绝经相关阴道和外阴萎缩的方法相比,阴道脱氢表雄酮。
Prz Menopauzalny. 2020 Dec;19(4):195-199. doi: 10.5114/pm.2020.101943. Epub 2021 Jan 7.
3
Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause.
维生素 D 补充对绝经后女性外阴阴道萎缩的影响。
Nutrients. 2020 Sep 21;12(9):2876. doi: 10.3390/nu12092876.
4
Treatment of genitourinary syndrome of menopause: the potential effects of intravaginal ultralow-concentration oestriol and intravaginal dehydroepiandrosterone on quality of life and sexual function.更年期泌尿生殖综合征的治疗:阴道内超低浓度雌三醇和阴道内脱氢表雄酮对生活质量和性功能的潜在影响。
Prz Menopauzalny. 2019 Jun;18(2):116-122. doi: 10.5114/pm.2019.86836. Epub 2019 Jun 28.
5
Prasterone: A Review in Vulvovaginal Atrophy.普拉睾酮:治疗外阴阴道萎缩的研究进展。
Drugs Aging. 2019 Aug;36(8):781-788. doi: 10.1007/s40266-019-00693-6.
6
Impact of vertical versus horizontal vaginal cuff closure on vaginal length following hysterectomy: a meta-analysis of randomized trials.子宫切除术后垂直与水平阴道残端闭合对阴道长度的影响:一项随机试验的荟萃分析
Int Urogynecol J. 2019 Aug;30(8):1239-1245. doi: 10.1007/s00192-019-03881-5. Epub 2019 Jan 29.